|
Please
download and print the PDF file below:
|
|
|
|
Lesley C. Dinwiddie, MSN, RN, FNP, CNN
|
Lesley C. Dinwiddie, MSN, RN, FNP, CNN, is
Nephrology Nurse Consultant in Vascular Access
Education and Research, and is President of the
American Nephrology Nurses’ Association (ANNA). |
Vascular
access is the leading cause of morbidity
in the hemodialysis patient population.
Arteriovenous fistulas (AVFs) have the
lowest complication rate while catheters
have the highest.
Though significant effort is being made
to increase the number of AVFs and lower
the number
of catheters, annual data show that the
number of catheters is increasing. To
improve vascular
access-related patient outcomes, catheter
dysfunction needs to be managed by a vascular
access team using the CQI process that
begins with a comprehensive algorithm
for treatment.
|
|
CE
RELATED INFORMATION |
|
This
offering for 2.2 contact
hours is being provided by the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing education
in nursing by the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity is
approved by most states and
specialty organizations that
recognize the ANCC-COA accreditation
process. ANNA is an approved
provider of continuing education
in nursing by the California
Board of Registered Nursing,
BRN Provider No. 00910.
|
|
Goal:
To increase awareness of the implications
of, and the methods for managing,
catheter dysfunction.
Objectives:
1.
Discuss the incidence of catheter dysfunction in
relationship to the number of people being
hemodialyzed for ESRD.
2. Describe three advantages in using lytic therapy for
dysfunction caused by thrombus.
3. Identify four essential team members in each nephron segment.
4. State three elements of the CQI process for
managing catheter dysfunction.
|
AUTHOR DISCLOSURE
STATEMENT |
Lesley C. Dinwiddie, MSN, RN, FNP, CNN
has no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |